GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer

MLA

Liping Ye, et al. “GINS2 Is a Novel Prognostic Biomarker and Promotes Tumor Progression in Early-Stage Cervical Cancer.” Oncology Reports, vol. 37, no. 5, Apr. 2017, pp. 2652–62. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8b81127857839fa6301e9fa7fdf66305&authtype=sso&custid=ns315887.

APA

Liping Ye, Junling Liu, Chuyong Lin, Fei Ouyang, Jing Wang, Peng Guo, Xianqiu Wu, Libing Song, Mian He, Jun Li, & Meng Xia. (2017). GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer. Oncology Reports, 37(5), 2652–2662.

Chicago

Liping Ye, Junling Liu, Chuyong Lin, Fei Ouyang, Jing Wang, Peng Guo, Xianqiu Wu, et al. 2017. “GINS2 Is a Novel Prognostic Biomarker and Promotes Tumor Progression in Early-Stage Cervical Cancer.” Oncology Reports 37 (5): 2652–62. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8b81127857839fa6301e9fa7fdf66305&authtype=sso&custid=ns315887.